Roots Analysis has done a detailed study on Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 400+ page report, which features 185+ figures and 235+ tables, please visit this link
Key Market Insights
- The elastomeric container closures market is fragmented, featuring the presence of a large number of established players; a relatively larger proportion of small-sized players are based in developing geographies
- Currently, there are over 240 closures, fabricated using a variety of elastomeric materials, available for use in parenteral primary packaging containers; majority of these products are available in the ready-to-use format
- Over time, companies have established preferences regarding fabrication materials for container-closure systems for different drug classes in order to ensure that their products are free from chemical impurities
- A number of conferences related to pharmaceutical packaging have been organized in the recent past; in addition, stakeholders have also entered into strategic agreements to strengthen their product portfolios
- In order to cope up with emerging trends in the pharmaceutical packaging market, it is important for container closure manufacturers to improve existing practices to cater to the changing needs of drug developers
- The global demand for elastomeric closures is presently driven by rising adoption of parenteral containers; in future, pre-sterilized and coated closures are anticipated to drive the demand at a relatively faster pace
- The overall market is poised to grow steadily; the opportunity is likely to be well-distributed across various types of containers, types of closures and regions
For more information, please visit https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
Table of Contents
- PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
- EXECUTIVE SUMMARY
- INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Types of Pharmaceutical Packaging
3.2.2. Innovation in Pharmaceutical Packaging
3.2.3. Traditional Aseptic Pharmaceutical Filling Operations
3.2.4. Limitations of Traditional Primary Packaging
3.3. Role of Containers-Closures Systems in Pharmaceutical Packaging
3.4. Types of Closures Used in Pharmaceutical Packaging
3.4.1. Closures for Prefilled Syringes / Syringes
3.4.2. Closures for Vials
3.4.3. Closures for Cartridges
3.5. Key Considerations for Choosing Materials for Fabricating Closures
3.6. Elastomeric Packaging Materials
3.6.1. Key Properties of Elastomeric Packaging Materials
3.6.2. Popular Types of Elastomeric Packaging Materials
3.6.3. Regulatory Guidelines for Elastomeric Closures
3.6.4. Manufacturing Process for Elastomeric Closures
3.6.5. Quality Assessment Tests for Elastomeric Closures
3.6.6. Advantages and Limitations of Elastomeric Packaging Materials
3.7. Concluding Remarks
- MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Elastomeric Closures for Parenteral Containers: List of Products
4.2.1. Analysis by Type of Closure
4.2.1.1. Analysis by Type of Closure and Headquarters of Manufacturer
4.2.1.2. Analysis by Type of Closure and Size of Player
4.2.2. Analysis by Type of Container
4.2.3. Analysis by Type of Elastomeric Material
4.2.4. Analysis by Drug Class
4.2.5. Analysis by Sterilization Status
4.2.6. Analysis by Sterilization Technique
4.2.7. Analysis by Type of Coating
4.3. Elastomeric Closures for Parenteral Containers: List of Manufacturers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Target Market
4.3.5. Analysis by Scale of Production
4.3.6. Leading Manufacturers: Analysis by Number of Products
4.3.7. Manufacturer Landscape: Analysis by Company Size and Location of Headquarters
4.4. Elastomeric Closures for Parenteral Containers: Recent Initiatives of Players
4.5. Concluding Remarks
- COMPANY PROFILES
5.1. Chapter Overview
5.2. Key Players Based in North America
5.2.1. Aptar Pharma (a Part of AptarGroup)
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Product Portfolio
5.2.1.4. Recent Developments and Future Outlook
5.2.2. DWK Life Sciences
5.2.2.1. Company Overview
5.2.2.2. Product Portfolio
5.2.2.3. Recent Developments and Future Outlook
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com